CDTX vs NTAP · rev $1.3M vs P/E 28, rev $6.57B
Cidara Therapeutics Inc (CDTX) versus NetApp Inc (NTAP) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
NetApp Inc (NTAP) is a software - infrastructure company listed on US.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported NTAP revenue for 2025-04-25 was $6.57B. Net income was $1.19B. Revenue was up 4.9% from 2024-04-26 to 2025-04-25. NTAP currently screens at market cap $35.43B and trailing P/E 28.2.
CDTX currently screens at market cap $6.96B. NTAP currently screens at market cap $35.43B and trailing P/E 28.2.
Not investment advice. Open the CDTX and NTAP stock pages for the full models.
Not investment advice.